Investors: 1 Dividend to Buy, 1 Dividend to Sell

Before you go, we thought you'd like these...
Before you go close icon

The following video is part of our "Motley Fool Conversations" series, in which technology editor/analyst Andrew Tonner and health-care editor/analyst David Williamson discuss topics across the investing world.

In this installation of our popular article series, Andrew and David sit down to talk about one dividend stock they like and one worth avoiding. David discusses GlaxoSmithKline, while Andrew talks about semiconductor powerhouse Qualcomm. With dividend investing all the rage right now, investors need to know exactly what they're buying before they invest. Listen on to find out which stock deserves some love and which you're better off passing on.

If you're interested in either of the companies here on your quest for great dividend-paying stocks, The Motley Fool has compiled a special FREE report outlining our 11 favorite, dependable, dividend-paying stocks. It's called "Secure Your Future With 11 Rock-Solid Dividend Stocks." You can access your complimentary copy today at no cost! Just click here to discover the winners we've picked.

At the time this article was published Andrew Tonner and David Williamson have no positions in the stocks mentioned above. The Motley Fool owns shares of Apple, Google, GlaxoSmithKline and Qualcomm.Motley Fool newsletter services recommendApple and Google. Try any of our Foolish newsletter servicesfree for 30 days. We Fools may not all hold the same opinions, but we all believe thatconsidering a diverse range of insightsmakes us better investors. The Motley Fool has adisclosure policy.

Copyright © 1995 - 2012 The Motley Fool, LLC. All rights reserved. The Motley Fool has a disclosure policy.

Read Full Story

Want more news like this?

Sign up for Finance Report by AOL and get everything from business news to personal finance tips delivered directly to your inbox daily!

Subscribe to our other newsletters

Emails may offer personalized content or ads. Learn more. You may unsubscribe any time.

From Our Partners